Q1 2017 Holdings
Filed 2017-05-15 | 119 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $887.7M | 25,819,768 | 53.1% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $421.9M | 4,806,483 | 25.2% |
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $134.5M | 3,673,175 | 8.0% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $98.4M | 11,716,784 | 5.9% |
| Cerus Corporation(CERS) | COM | 157085101 | $58.1M | 13,053,275 | 3.5% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $37.8M | 1,351,463 | 2.3% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $9.9M | 5,102,153 | 0.6% |
| Agios Pharmaceuticals, Inc.(AGIO) | COM | 00847X104 | $7.5M | 128,666 | 0.4% |
| Incyte Corporation(INCY) | COM | 45337C102 | $4.6M | 34,110,011 | 0.3% |
| Biogen Inc.(BIIB) | COM | 09062X103 | $4.5M | 16,500 | 0.3% |
| Seattle Genetics, Inc. | COM | 812578102 | $2.9M | 45,715,556 | 0.2% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.2M | 50,000 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $793.4K | 6,544,130 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $587.0K | 180,582 | 0.0% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $551.0K | 100,000 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $433.6K | 13,770,982 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $194.0K | 5,509,560 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $182.5K | 10,934,154 | 0.0% |
| Achaogen, Inc. | COM | 004449104 | $115.6K | 4,582,382 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 1.875% 4/23/2017 | 09061GAD3 | $96.0K | $22,379,000 | 0.0% |
| Advanced Accelerator Applications S.A. | SPONSORED ADS | 00790T100 | $88.6K | 2,221,706 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $80.6K | 7,288,300 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $72.5K | 22,656,469 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $70.3K | 1,318,341 | 0.0% |
| Acorda Therapeutics, Inc. | COM | 00484M106 | $69.3K | 3,301,791 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $62.1K | 5,032,313 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $56.4K | 2,603,569 | 0.0% |
| Novavax, Inc. | Note 3.75% 2/1/2023 ADDED | 670002AB0 | $48.6K | $108,500,000 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $41.8K | 2,783,569 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $38.8K | 895,422 | 0.0% |
| AveXis, Inc. | COM | 05366U100 | $38.0K | 500,000 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $35.5K | 1,660,593 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $31.9K | 351,441 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $29.7K | 3,150,808 | 0.0% |
| Acorda Therapeutics, Inc. | NOTE 1.75% 6/15/2021 | 00484MAA4 | $29.7K | $35,083,000 | 0.0% |
| Merus N.V. | COM | N5749R100 | $28.3K | 1,160,014 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $25.4K | 10,286,483 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $23.6K | 4,530,901 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $22.4K | 259,894 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $20.9K | 872,072 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $18.0K | 1,391,507 | 0.0% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $15.2K | 571,667 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $15.0K | 1,062,120 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $14.8K | 208,328 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $14.6K | 673,908 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $14.2K | 1,585,913 | 0.0% |
| Dermira, Inc.(DERMEUR) | COM | 24983L104 | $14.2K | 415,448 | 0.0% |
| BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | $13.8K | $12,228,000 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $13.6K | 299,356 | 0.0% |
| Aegerion Pharmaceuticals, Inc. | NOTE 2.0% 8/15/2019 | 00767EAB8 | $13.2K | $16,517,000 | 0.0% |